Euroapi S.A.S.U [EAPI] vs AB Science S.A [AB] Detailed Stock Comparison

Euroapi S.A.S.U.

EURONEXT
Loading...

AB Science S.A.

EURONEXT
Loading...

TLDR: Quick Comparison Summary

Based on 17 vital metrics comparison: Euroapi S.A.S.U. wins in 11 metrics, AB Science S.A. wins in 5 metrics, with 0 ties. Euroapi S.A.S.U. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Euroapi S.A.S.U. AB Science S.A. Better
P/E Ratio (TTM) 8.84 -7.73 Euroapi S.A.S.U.
Price-to-Book Ratio 0.21 N/A N/A
Debt-to-Equity Ratio 8.30 -0.80 Euroapi S.A.S.U.
PEG Ratio -10.00 -8.24 AB Science S.A.
EV/EBITDA 0.56 -19.47 Euroapi S.A.S.U.
Profit Margin (TTM) -24.77% 116.42% AB Science S.A.
Operating Margin (TTM) -2.24% -529.71% Euroapi S.A.S.U.
Return on Equity -23.84% 32.97% AB Science S.A.
Return on Assets (TTM) 0.16% -14.79% Euroapi S.A.S.U.
Free Cash Flow (TTM) $50.00M $370,000 Euroapi S.A.S.U.
1-Year Return 19.20% -17.95% Euroapi S.A.S.U.
Price-to-Sales Ratio (TTM) 0.14 74.37 Euroapi S.A.S.U.
Enterprise Value $72.68M $91.64M AB Science S.A.
EV/Revenue Ratio 0.09 89.23 Euroapi S.A.S.U.
Revenue per Share (TTM) $9 $0 Euroapi S.A.S.U.
Earnings per Share (Diluted) $-2.23 $-0.15 AB Science S.A.
Beta (Stock Volatility) 0.95 1.29 Euroapi S.A.S.U.

Euroapi S.A.S.U. vs AB Science S.A. Stock Performance Analysis

Loading Price Chart...

EAPI
AB

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Euroapi S.A.S.U.-1.53%-10.27%-9.03%3.15%3.15%3.15%
AB Science S.A.1.94%-3.13%-7.00%-28.46%-21.19%-36.30%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Euroapi S.A.S.U.19.20%19.20%19.20%19.20%19.20%19.20%
AB Science S.A.-17.95%-78.71%-91.41%-94.07%-89.18%-89.18%

Performance & Financial Health Analysis: Euroapi S.A.S.U. vs AB Science S.A.

MetricEAPIAB
Market Information
Market Cap i€121.46M€76.77M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i119,972154,364
90 Day Avg. Volume i165,692117,735
Last Close€1.29€0.95
52 Week Range€1.22 - €3.57€0.91 - €1.73
% from 52W High-64.00%-45.20%
All-Time High€19.01 (Oct 24, 2022)€23.00 (Oct 29, 2012)
% from All-Time High-93.21%-95.87%
Growth Metrics
Quarterly Revenue Growth-0.06%-0.08%
Quarterly Earnings GrowthN/AN/A
Financial Health
Profit Margin (TTM) i-0.25%1.16%
Operating Margin (TTM) i-0.02%-5.30%
Return on Equity (TTM) i-0.24%0.33%
Debt to Equity (MRQ) i8.30-0.80
Cash & Liquidity
Book Value per Share (MRQ)€6.18€-0.41
Cash per Share (MRQ)€1.20€0.08
Operating Cash Flow (TTM) i€128.50M€-6,878,000
Levered Free Cash Flow (TTM) i€157.46M€-2,463,500
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Euroapi S.A.S.U. vs AB Science S.A.

MetricEAPI (Apr 24, 2026)AB (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i8.84-7.73
Forward P/E i-10.00-8.24
PEG Ratio i-10.00-8.24
Price to Sales (TTM) i0.1474.37
Price to Book (MRQ) i0.21N/A
Market Capitalization
Market Capitalization i€121.46M€76.77M
Enterprise Value i€72.68M€91.64M
Enterprise Value Metrics
Enterprise to Revenue i0.0989.23
Enterprise to EBITDA i0.56-19.47
Risk & Other Metrics
Beta i0.951.29
Book Value per Share (MRQ) i€6.18€-0.41

Financial Statements Comparison: Euroapi S.A.S.U. vs AB Science S.A.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricEAPI (2025)AB (2024)
Revenue/Sales i852.60M1.07M
Cost of Goods Sold i707.70M-176,000
COGS % of Revenue i83.0%-16.4%
Gross Profit i144.80M1.25M
Gross Margin i17.0%116.4%
Research & Development i27.30M3.94M
Operating Income (EBIT) i1.70M-6.08M
Operating Margin i0.2%-567.4%
EBITDA i141.50M-5.12M
EBITDA Margin i16.6%-477.5%
Pre-Tax Income i-138.20M-7.83M
Pre-Tax Income % of Revenue i-16.2%-730.6%
Income Tax i72.90MN/A
Income Tax % of Revenue i8.6%0.0%
Net Income (Profit) i-211.20M-7.83M
Profit Margin i-24.8%-730.5%

Balance Sheet & Liquidity Metrics

MetricEAPI (2025)AB (2024)
Cash & Equivalents i113.80M7.99M
Total Current Assets i768.40M14.52M
Total Current Assets % of Revenue i90.1%1,354.9%
Total Current Liabilities i295.20M20.43M
Total Current Liabilities % of Revenue i34.6%1,906.1%
Long-Term Debt i16.30M14.55M
Long-Term Debt % of Revenue i1.9%1,357.2%
Total Shareholders Equity i788.20M-23.75M
Retained Earnings iN/AN/A
Retained Earnings % of Revenue i0.0%0.0%
Property, Plant & Equipment i11.10M256,000

Cash Flow Statement Comparison

MetricEAPI (2025)AB (2024)
Operating Cash Flow i-82.10M-6.20M
Operating Cash Flow % of Revenue i-9.6%-577.9%
Capital Expenditures i-77.00M-136,000
Free Cash Flow i50.00M370,000
FCF Margin i5.9%34.5%
Debt Repayment iN/A-2.36M
Common Stock Repurchase i0N/A

Short Interest & Institutional Ownership Analysis

MetricEAPIAB
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i95.19M64.64M
Float Shares i50.46M25.41M
% Held by Insiders i34.99%30.80%
% Held by Institutions i36.55%0.01%
% Held by Public i28.46%69.19%

Dividend Analysis & Yield Comparison: Euroapi S.A.S.U. vs AB Science S.A.

MetricEAPIAB
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A